Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.3 SEK | -1.69% | +1.09% | +4.97% |
May. 08 | Vimab Group AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 08 | Vimab Group AB (OM:VIMAB) agreed to acquire Tranfoten Aktiebolag. | CI |
Valuation
Fiscal Period: December | 2022 | 2023 |
---|---|---|
Capitalization 1 | 172.2 | 191.2 |
Enterprise Value (EV) 1 | 194.4 | 293.9 |
P/E ratio | -2.58 x | -43.6 x |
Yield | - | - |
Capitalization / Revenue | 0.76 x | 0.56 x |
EV / Revenue | 0.86 x | 0.86 x |
EV / EBITDA | 29.4 x | 11.7 x |
EV / FCF | 9,407,548 x | -10,808,709 x |
FCF Yield | 0% | -0% |
Price to Book | 3.03 x | 2.52 x |
Nbr of stocks (in thousands) | 19,397 | 21,581 |
Reference price 2 | 8.880 | 8.860 |
Announcement Date | 5/23/23 | 3/12/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net sales 1 | 216.8 | 203.3 | 227.3 | 342.4 |
EBITDA 1 | 4.802 | -4.363 | 6.615 | 25.16 |
EBIT 1 | -18.84 | -21.23 | -14.17 | -0.014 |
Operating Margin | -8.69% | -10.44% | -6.23% | -0% |
Earnings before Tax (EBT) 1 | -46.09 | -24.64 | -31.82 | -5.247 |
Net income 1 | -46.29 | -24.09 | -34.22 | -4.259 |
Net margin | -21.34% | -11.85% | -15.06% | -1.24% |
EPS | - | -1.242 | -3.444 | -0.2032 |
Free Cash Flow | - | -2.09 | 20.66 | -27.19 |
FCF margin | - | -1.03% | 9.09% | -7.94% |
FCF Conversion (EBITDA) | - | - | 312.32% | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 7/21/22 | 7/21/22 | 5/23/23 | 3/12/24 |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
Net Debt 1 | 141 | - | 22.1 | 103 |
Net Cash position 1 | - | 5.75 | - | - |
Leverage (Debt/EBITDA) | 29.35 x | - | 3.343 x | 4.08 x |
Free Cash Flow | - | -2.09 | 20.7 | -27.2 |
ROE (net income / shareholders' equity) | - | -204% | -51.2% | -8.94% |
ROA (Net income/ Total Assets) | - | -7.71% | -4.86% | -0% |
Assets 1 | - | 312.4 | 704.3 | 133,094 |
Book Value Per Share | - | 3.960 | 2.930 | 3.520 |
Cash Flow per Share | - | 0.9800 | 0.6900 | 1.360 |
Capex 1 | 6.48 | 6.58 | 7.05 | - |
Capex / Sales | 2.99% | 3.24% | 3.1% | - |
Announcement Date | 7/21/22 | 7/21/22 | 5/23/23 | 3/12/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
+4.97% | 20.06M | |
+9.01% | 7.53B | |
-35.75% | 3.09B | |
+4.71% | 2.67B | |
-4.80% | 1.47B | |
-15.85% | 1.01B | |
+10.34% | 760M | |
-13.42% | 656M | |
-2.77% | 616M | |
-10.83% | 603M |
- Stock Market
- Equities
- VIMAB Stock
- Financials Vimab Group AB